Guru Ownership Trend
Guru Analysis for BioCryst Pharmaceuticals, Inc. (BCRX)
BioCryst Pharmaceuticals, Inc. (BCRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $49.01 M.
Top institutional holders include Ken Fisher and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $20.43 M net outflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 170.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 63.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for BioCryst Pharmaceuticals, Inc. (BCRX)
Major holders include Ken Fisher ($26.02 M), Renaissance Technologies (RenTech) ($7.4 M), Ray Dalio ($6.07 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 4.9 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $20.43 M, with 3 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 3 fully exited BCRX. The total reported sell value was $27.71 M.
Yes, 0 managers opened new positions in BCRX, and 3 increased their existing holdings. The total reported buy value was $7.28 M.